IRIS
DE ANGELIS, BIAGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.202
AS - Asia 919
EU - Europa 748
SA - Sud America 124
Continente sconosciuto - Info sul continente non disponibili 68
AF - Africa 28
Totale 3.089
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.141
SG - Singapore 420
RU - Federazione Russa 348
VN - Vietnam 163
CN - Cina 143
IT - Italia 126
BR - Brasile 106
HK - Hong Kong 82
DE - Germania 60
FR - Francia 45
FI - Finlandia 41
CA - Canada 34
BD - Bangladesh 26
GB - Regno Unito 26
IE - Irlanda 26
NL - Olanda 25
JP - Giappone 23
IN - India 16
MX - Messico 12
PL - Polonia 11
UA - Ucraina 9
SE - Svezia 7
ZA - Sudafrica 7
AR - Argentina 6
ES - Italia 5
JM - Giamaica 5
LT - Lituania 5
PH - Filippine 5
CI - Costa d'Avorio 4
ID - Indonesia 4
IQ - Iraq 4
PK - Pakistan 4
TH - Thailandia 4
TR - Turchia 4
AT - Austria 3
BE - Belgio 3
BW - Botswana 3
IL - Israele 3
SC - Seychelles 3
VE - Venezuela 3
CH - Svizzera 2
CL - Cile 2
CO - Colombia 2
CR - Costa Rica 2
DZ - Algeria 2
EC - Ecuador 2
GT - Guatemala 2
HR - Croazia 2
KR - Corea 2
NP - Nepal 2
PY - Paraguay 2
SN - Senegal 2
TW - Taiwan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GN - Guinea 1
GP - Guadalupe 1
HT - Haiti 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MA - Marocco 1
ML - Mali 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.023
Salva come PNG Salva come JPEG
Città #
San Jose 197
Singapore 180
Ashburn 107
Chandler 93
Hong Kong 74
Council Bluffs 69
Moscow 63
Beijing 49
Ho Chi Minh City 41
Munich 37
Santa Clara 37
Hanoi 36
Millbury 28
The Dalles 25
Frisco 23
Rome 23
Buffalo 21
Los Angeles 21
Turku 21
Dong Ket 20
Lauterbourg 20
Amsterdam 18
New York 17
Tokyo 17
São Paulo 15
Des Moines 14
Napoli 14
Dallas 13
Lawrence 13
London 12
Naples 12
Dublin 9
Princeton 9
Toronto 9
Atlanta 8
Boston 8
Frankfurt am Main 8
Nanjing 8
Nuremberg 8
Phoenix 8
Redondo Beach 8
Warsaw 8
Wilmington 8
Chennai 7
Haiphong 7
Orem 7
Seattle 7
Brooklyn 6
Da Nang 6
Helsinki 6
Milan 6
Ottawa 6
Poplar 6
Chicago 5
Lappeenranta 5
Miami 5
Montreal 5
Rio de Janeiro 5
Falkenstein 4
Johannesburg 4
Mexico City 4
Redwood City 4
Salvador 4
San Francisco 4
Stockholm 4
Tianjin 4
Brussels 3
Denver 3
Fairfield 3
Frosinone 3
Guangzhou 3
Hefei 3
Houston 3
Jiaxing 3
Kingston 3
Nanchang 3
Praia Grande 3
Sant'agata De' Goti 3
Woodbridge 3
Ankara 2
Bari 2
Bastia 2
Birmingham 2
Brescia 2
Cabo Frio 2
Changsha 2
Columbus 2
Concord 2
Curitiba 2
Dakar 2
Dalian 2
Gaborone 2
Genoa 2
Giugliano In Campania 2
Guarulhos 2
Guatemala City 2
Guidonia 2
Juiz de Fora 2
Kochi 2
Kyiv 2
Totale 1.631
Salva come PNG Salva come JPEG
Nome #
Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies 179
UNA BASSA ESPRESSIONE DELLA FOSFATASI SHP-1 CORRELA CON LA RESI-STENZA AL TRATTAMENTO CON INIBITORI DELLE TIROSIN KINASI IN PAZIENTIAFFETTI DA LEUCEMIA MIELOIDE CRONICA 165
MOLECULAR EVALUATION OF ZNF224 MRNA EXPRESSION IN CML PATIENTS AS A NOVEL DETERMINANT OF TKI RESPONSIVENESS 157
Adoptive immunotherapy using prame-specific t cells in medulloblastoma 148
L'ATTIVITÀ DEGLI INIBITORI DI TIROSINA KINASI (TKI) SULLA PROLIFERAZIONE E L'ATTIVAZIONE DELLE CELLULE T 144
WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene 144
FGFR1 is a potential therapeutic target in neuroblastoma 143
CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T-cells 140
Analysis of Bone Marrow Microenviroment Factors As Early Markers of Response in Patients with Newly Diagnosed Bcr-Abl Positive CML in Chronic Phase Treated with Nilotinib. 137
PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanism 129
Molecular monitoring in chronic myeloid leukemia (CML) 120
Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia. 116
Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma 115
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia 115
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model 113
Human CAR NK cells: A new non-viral method allowing high efficient transfection and strong tumor cell killing 113
Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells 106
Generation of Epstein Barr Virus Specific Cytotoxic T Lymphocytes (EBV-CTLs) Resistant to the Immunosuppressive Drug Tacrolimus (FK506) 99
Overcoming challenges in CAR T-cell product CGMP release 95
Induction of PRAME-specific immunity by overlapping pentadecapeptides in patients with hematologic malignancies 93
Generation of EBV specific cytotoxic T lymphocytes (EBV-CTLs) resistant to the immunosuppressive drug FK506 89
European survey on CAR T-Cell analytical methods from apheresis to post-infusion immunomonitoring 85
Stimuli-responsive nanoparticle-assisted immunotherapy: A new weapon against solid tumours 85
A biodegradable hydrogel based on carboxymethyl cellulose/silver nanoparticles for wound closures 18
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting 13
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside? 12
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial 12
GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma 11
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma 11
GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape 10
NK cells as adoptive cellular therapy for hematological malignancies: Advantages and hurdles 10
Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell Immunotherapy 10
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL 10
PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic Approaches 9
An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model 9
GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous system 9
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling 9
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia 8
Nanoparticles for Diagnosis and Target Therapy in Pediatric Brain Cancers 8
The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors 8
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases 8
Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas 7
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies 7
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia 7
Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3-FOXO1 rhabdomyosarcoma 6
Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We? 6
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant 6
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation 5
Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation 5
Time to evolve: predicting engineered T cell-associated toxicity with next-generation models 5
MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression 5
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts 5
Prolonged overall survival in a child with multimetastatic retinoblastoma treated with anti-GD2 monoclonal antibody dinutuximab beta: a case report 5
Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma 5
Totale 3.089
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.594
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022152 0 0 0 1 0 2 0 6 27 6 57 53
2022/2023219 22 13 8 4 32 25 8 33 36 17 15 6
2023/2024113 6 22 12 9 5 11 2 11 2 3 20 10
2024/2025735 29 20 0 9 19 51 68 63 48 73 274 81
2025/20261.448 155 62 155 135 255 52 163 48 140 117 105 61
2026/2027255 82 138 35 0 0 0 0 0 0 0 0 0
Totale 3.089